Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)
- 30 June 2007
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 192 (2), 432-437
- https://doi.org/10.1016/j.atherosclerosis.2006.11.037
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The effect of 24 months of combination statin and extended-release niacin on carotid intima‐media thickness: ARBITER 3Current Medical Research and Opinion, 2006
- AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood InstituteJournal of the American College of Cardiology, 2006
- Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2Circulation, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Extended-release niacin for modifying the lipoprotein profileExpert Opinion on Pharmacotherapy, 2004
- Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary DiseaseThe New England Journal of Medicine, 2001
- National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).Circulation, 1994